Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: phosphatidylcholine-complexed therapeutics - PLx Pharma

Next Previous
X
Search
Drug Profile

Research programme: phosphatidylcholine-complexed therapeutics - PLx Pharma

Alternative Names: Indometacin/phosphatidylcholine; Indomethacin-PC; Indomethacin/phosphatidylcholine; Ketorolac/phosphatidylcholine; Meloxicam/phosphatidylcholine; Mesalazine (PL9100 5-ASA); Piroxicam-PC; Piroxicam/phosphatidylcholine; PL 4100; PL 4500; PL 9100 5-ASA

Latest Information Update: 17 Jul 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator
  • Developer PLx Pharma
  • Class
  • Mechanism of Action Cyclooxygenase inhibitors; Lipoxygenase-cyclooxygenase inhibitors; Prostaglandin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Congenital heart defects; Gout; Inflammation; Pain; Ulcerative colitis

Most Recent Events

  • 12 Apr 2023 Greenwood Brands acquires all the assets of PLx Pharma
  • 24 Feb 2023 Discontinued - Preclinical for Congenital heart defects in USA (IV) (PLx Pharma pipeline, February 2023)
  • 28 Oct 2018 No recent reports of development identified for preclinical development in Congenital-heart-disorders in USA (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top